583 related articles for article (PubMed ID: 28131417)
1. miR-18a-5p Inhibits Sub-pleural Pulmonary Fibrosis by Targeting TGF-β Receptor II.
Zhang Q; Ye H; Xiang F; Song LJ; Zhou LL; Cai PC; Zhang JC; Yu F; Shi HZ; Su Y; Xin JB; Ma WL
Mol Ther; 2017 Mar; 25(3):728-738. PubMed ID: 28131417
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between pleural mesothelial cell and lung fibroblast contributes to pulmonary fibrosis.
Liu F; Yu F; Lu YZ; Cheng PP; Liang LM; Wang M; Chen SJ; Huang Y; Song LJ; He XL; Xiong L; Xin JB; Ma WL; Ye H
Biochim Biophys Acta Mol Cell Res; 2020 Nov; 1867(11):118806. PubMed ID: 32739525
[TBL] [Abstract][Full Text] [Related]
3. miR-9-5p suppresses pro-fibrogenic transformation of fibroblasts and prevents organ fibrosis by targeting NOX4 and TGFBR2.
Fierro-Fernández M; Busnadiego Ó; Sandoval P; Espinosa-Díez C; Blanco-Ruiz E; Rodríguez M; Pian H; Ramos R; López-Cabrera M; García-Bermejo ML; Lamas S
EMBO Rep; 2015 Oct; 16(10):1358-77. PubMed ID: 26315535
[TBL] [Abstract][Full Text] [Related]
4. Cigarette smoking aggravates bleomycin-induced experimental pulmonary fibrosis.
Zhou LL; Wang M; Liu F; Lu YZ; Song LJ; Xiong L; Xiang F; He XL; Shuai SY; Xin JB; Ye H; Yu F; Ma WL
Toxicol Lett; 2019 Mar; 303():1-8. PubMed ID: 30572104
[TBL] [Abstract][Full Text] [Related]
5. M2 macrophages induce EMT through the TGF-β/Smad2 signaling pathway.
Zhu L; Fu X; Chen X; Han X; Dong P
Cell Biol Int; 2017 Sep; 41(9):960-968. PubMed ID: 28493530
[TBL] [Abstract][Full Text] [Related]
6. miR-1343 attenuates pathways of fibrosis by targeting the TGF-β receptors.
Stolzenburg LR; Wachtel S; Dang H; Harris A
Biochem J; 2016 Feb; 473(3):245-56. PubMed ID: 26542979
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of miR-182-5p attenuates pulmonary fibrosis via TGF-β/Smad pathway.
Chen Y; Zhang Q; Zhou Y; Yang Z; Tan M
Hum Exp Toxicol; 2020 May; 39(5):683-695. PubMed ID: 31884830
[TBL] [Abstract][Full Text] [Related]
8. miR-26a suppresses EMT by disrupting the Lin28B/let-7d axis: potential cross-talks among miRNAs in IPF.
Liang H; Liu S; Chen Y; Bai X; Liu L; Dong Y; Hu M; Su X; Chen Y; Huangfu L; Li X; Gu Y; Shan H
J Mol Med (Berl); 2016 Jun; 94(6):655-65. PubMed ID: 26787543
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of Long Noncoding RNA H19 Represses the Progress of Pulmonary Fibrosis through the Transforming Growth Factor β/Smad3 Pathway by Regulating MicroRNA 140.
Wang X; Cheng Z; Dai L; Jiang T; Jia L; Jing X; An L; Wang H; Liu M
Mol Cell Biol; 2019 Jun; 39(12):. PubMed ID: 30988156
[TBL] [Abstract][Full Text] [Related]
10. Bleomycin induced epithelial-mesenchymal transition (EMT) in pleural mesothelial cells.
Chen LJ; Ye H; Zhang Q; Li FZ; Song LJ; Yang J; Mu Q; Rao SS; Cai PC; Xiang F; Zhang JC; Su Y; Xin JB; Ma WL
Toxicol Appl Pharmacol; 2015 Mar; 283(2):75-82. PubMed ID: 25595642
[TBL] [Abstract][Full Text] [Related]
11. Tetraspanin 1 as a mediator of fibrosis inhibits EMT process and Smad2/3 and beta-catenin pathway in human pulmonary fibrosis.
Liu G; Wang Y; Yang L; Zou B; Gao S; Song Z; Lin Z
J Cell Mol Med; 2019 May; 23(5):3583-3596. PubMed ID: 30869194
[TBL] [Abstract][Full Text] [Related]
12. miR‑221 targets HMGA2 to inhibit bleomycin‑induced pulmonary fibrosis by regulating TGF‑β1/Smad3-induced EMT.
Wang YC; Liu JS; Tang HK; Nie J; Zhu JX; Wen LL; Guo QL
Int J Mol Med; 2016 Oct; 38(4):1208-16. PubMed ID: 27513632
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of microRNA-9 reduces inflammatory response and fibroblast proliferation in mice with idiopathic pulmonary fibrosis through the ANO1-mediated TGF-β-Smad3 pathway.
Dai WJ; Qiu J; Sun J; Ma CL; Huang N; Jiang Y; Zeng J; Ren BC; Li WC; Li YH
J Cell Physiol; 2019 Mar; 234(3):2552-2565. PubMed ID: 30144053
[TBL] [Abstract][Full Text] [Related]
14. MALAT1 Modulates TGF-β1-Induced Endothelial-to-Mesenchymal Transition through Downregulation of miR-145.
Xiang Y; Zhang Y; Tang Y; Li Q
Cell Physiol Biochem; 2017; 42(1):357-372. PubMed ID: 28535533
[TBL] [Abstract][Full Text] [Related]
15. VEGF/Src signaling mediated pleural barrier damage and increased permeability contributes to subpleural pulmonary fibrosis.
Lu YZ; Liang LM; Cheng PP; Xiong L; Wang M; Song LJ; Yu F; He XL; Xiong L; Wang XR; Xin JB; Ye H; Ma WL
Am J Physiol Lung Cell Mol Physiol; 2021 Jun; 320(6):L990-L1004. PubMed ID: 33787325
[TBL] [Abstract][Full Text] [Related]
16. MiR-326-mediated overexpression of NFIB offsets TGF-β induced epithelial to mesenchymal transition and reverses lung fibrosis.
Pattnaik B; Negi V; Chaudhuri R; Desiraju K; Faizan MI; Akhtar A; Ansari MS; Shakir M; Gheware A; Prakash YS; Guleria R; Ghosh B; Agrawal A; Ahmad T
Cell Mol Life Sci; 2023 Nov; 80(12):357. PubMed ID: 37950757
[TBL] [Abstract][Full Text] [Related]
17. Antifibrotic role of αB-crystallin inhibition in pleural and subpleural fibrosis.
Bellaye PS; Burgy O; Colas J; Fabre A; Marchal-Somme J; Crestani B; Kolb M; Camus P; Garrido C; Bonniaud P
Am J Respir Cell Mol Biol; 2015 Feb; 52(2):244-52. PubMed ID: 25032514
[TBL] [Abstract][Full Text] [Related]
18. Integrated analyses identify the involvement of microRNA-26a in epithelial-mesenchymal transition during idiopathic pulmonary fibrosis.
Liang H; Gu Y; Li T; Zhang Y; Huangfu L; Hu M; Zhao D; Chen Y; Liu S; Dong Y; Li X; Lu Y; Yang B; Shan H
Cell Death Dis; 2014 May; 5(5):e1238. PubMed ID: 24853416
[TBL] [Abstract][Full Text] [Related]
19. The anti-fibrotic effects of microRNA-153 by targeting TGFBR-2 in pulmonary fibrosis.
Liang C; Li X; Zhang L; Cui D; Quan X; Yang W
Exp Mol Pathol; 2015 Oct; 99(2):279-85. PubMed ID: 26216407
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of mTOR ameliorates bleomycin-induced pulmonary fibrosis by regulating epithelial-mesenchymal transition.
Han Q; Lin L; Zhao B; Wang N; Liu X
Biochem Biophys Res Commun; 2018 Jun; 500(4):839-845. PubMed ID: 29704504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]